Here, we show that loss of endothelial expression of the IL-6 pathway inhibitor SOCS3 promoted a type I IFN–like (IFNI-like) gene signature in response to endotoxemia in mouse kidneys and brains. The gene discussed is IL6; the disease is serum lipopolysaccharide activity.